Bleakley Financial Group LLC Makes New $240,000 Investment in Healthpeak Properties, Inc. (NYSE:DOC)

Bleakley Financial Group LLC acquired a new stake in Healthpeak Properties, Inc. (NYSE:DOC) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 10,484 shares of the real estate investment trust’s stock, valued at approximately $240,000.

Several other large investors also recently modified their holdings of DOC. Douglas Lane & Associates LLC acquired a new position in Healthpeak Properties in the 3rd quarter valued at about $33,947,000. Presima Securities ULC bought a new stake in shares of Healthpeak Properties during the third quarter worth approximately $22,465,000. AMF Tjanstepension AB acquired a new position in shares of Healthpeak Properties in the third quarter valued at approximately $15,548,000. Handelsbanken Fonder AB bought a new position in shares of Healthpeak Properties during the third quarter worth approximately $11,668,000. Finally, Brookstone Capital Management acquired a new stake in Healthpeak Properties during the 3rd quarter worth approximately $11,018,000. 93.57% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on DOC shares. StockNews.com lowered Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Saturday, October 19th. Wells Fargo & Company restated an “equal weight” rating and issued a $23.00 price target (up from $22.00) on shares of Healthpeak Properties in a research note on Tuesday, October 1st. Wedbush lifted their price objective on shares of Healthpeak Properties from $22.00 to $25.00 and gave the stock an “outperform” rating in a research note on Monday, July 29th. Deutsche Bank Aktiengesellschaft raised shares of Healthpeak Properties from a “hold” rating to a “buy” rating and boosted their price objective for the company from $20.00 to $28.00 in a report on Monday. Finally, Royal Bank of Canada raised their target price on shares of Healthpeak Properties from $22.00 to $25.00 and gave the stock an “outperform” rating in a report on Tuesday, July 30th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating, nine have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Healthpeak Properties currently has a consensus rating of “Moderate Buy” and an average target price of $22.62.

Healthpeak Properties Price Performance

Healthpeak Properties stock opened at $23.12 on Thursday. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.70 and a current ratio of 0.70. Healthpeak Properties, Inc. has a 52 week low of $15.24 and a 52 week high of $23.15. The stock has a market capitalization of $16.27 billion, a P/E ratio of 66.06, a price-to-earnings-growth ratio of 2.27 and a beta of 1.14. The stock has a fifty day moving average of $22.21 and a 200-day moving average of $20.62.

Healthpeak Properties (NYSE:DOC) last issued its earnings results on Thursday, July 25th. The real estate investment trust reported $0.21 EPS for the quarter, missing the consensus estimate of $0.44 by ($0.23). Healthpeak Properties had a return on equity of 3.51% and a net margin of 11.93%. The business had revenue of $695.50 million for the quarter, compared to analyst estimates of $665.11 million. During the same period in the previous year, the firm posted $0.45 EPS. The firm’s revenue was up 27.5% compared to the same quarter last year. On average, sell-side analysts expect that Healthpeak Properties, Inc. will post 1.8 earnings per share for the current fiscal year.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.